April 17, 2017
Article
The investigational tyrosine kinase inhibitor quizartinib is extremely promising as a monotherapy for patients with FLT3-ITD–positive relapsed acute myeloid leukemia.
February 08, 2017
Article
The combination of nilotinib and trametinib proved to be synergistic in BRAF/NRAS wild-type melanoma, according to a recent study presented at the 2016 Society for Melanoma Research Congress.
January 06, 2017
Article
Tanios Bekaii-Saab, MD, discusses questions regarding regorafenib and TAS-102 in mCRC, compares the mechanisms of action and toxicities of both therapies, and shares his views on the optimal sequencing of the 2 agents.
December 23, 2016
Article
Alan P. Venook, MD, discusses several of the big queries that remain in mCRC and the possible explanations for survival differences between left- and right-sided tumors. He also explained how answering these questions could pave the way for more novel treatment approaches.
December 02, 2016
Article
Women who have been vaccinated against HPV can undergo less-intensive cervical cancer screening than is currently recommended.
November 28, 2016
Article
Findings of a new study revealed that less than half of patients with advanced cervical cancer are receiving all 3 of the therapies considered standard of care (SOC) for the disease.